NCT04511000View on ClinicalTrials.gov

Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

May 20, 2019

Study Completion Date

May 20, 2019

Conditions
Hypercholesterolemia
Interventions
DRUG

Lipilou®(generic atorvastatin drug) 20 mg

Patients assigned to experimental group are treated with Lipilou® 20 mg

DRUG

Lipilou®(generic atorvastatin drug) 10 mg

Patients assigned to comparator group are treated with Lipilou® 10 mg

Trial Locations (10)

Unknown

Korea University Ansan Hospital, Ansan

Sejong General Hospital, Bucheon-si

Dong-A University Hospital, Busan

Inje University Ilsan Paik Hospital, Goyang

Myongji Hospital, Goyang

Seoul National University Bundang Hospital, Seongnam

Korea University Guro Hospital, Seoul

Ulsan University Hospital, Ulsan

Wonju Severance Christian Hospital, Wŏnju

Pusan National University Yangsan Hospital, Yangsan

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY